Research ArticleArticle
Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets
Matthew T. Duvernay, Kayla J. Temple, Jae G. Maeng, Anna L. Blobaum, Shaun R. Stauffer, Craig W. Lindsley and Heidi E. Hamm
Molecular Pharmacology January 2017, 91 (1) 39-47; DOI: https://doi.org/10.1124/mol.116.106666
Matthew T. Duvernay
Department of Pharmacology (M.T.D., K.J.T., J.G.M., A.L.B., S.R.S., C.W.L., H.E.H.) and Vanderbilt Center for Neuroscience Drug Discovery (K.J.T., A.L.B., S.R.S., C.W.L.), Vanderbilt University Medical Center, Nashville, Tennessee; and Department of Chemistry, Vanderbilt University, Nashville, Tennessee (S.R.S., C.W.L.)
Kayla J. Temple
Department of Pharmacology (M.T.D., K.J.T., J.G.M., A.L.B., S.R.S., C.W.L., H.E.H.) and Vanderbilt Center for Neuroscience Drug Discovery (K.J.T., A.L.B., S.R.S., C.W.L.), Vanderbilt University Medical Center, Nashville, Tennessee; and Department of Chemistry, Vanderbilt University, Nashville, Tennessee (S.R.S., C.W.L.)
Jae G. Maeng
Department of Pharmacology (M.T.D., K.J.T., J.G.M., A.L.B., S.R.S., C.W.L., H.E.H.) and Vanderbilt Center for Neuroscience Drug Discovery (K.J.T., A.L.B., S.R.S., C.W.L.), Vanderbilt University Medical Center, Nashville, Tennessee; and Department of Chemistry, Vanderbilt University, Nashville, Tennessee (S.R.S., C.W.L.)
Anna L. Blobaum
Department of Pharmacology (M.T.D., K.J.T., J.G.M., A.L.B., S.R.S., C.W.L., H.E.H.) and Vanderbilt Center for Neuroscience Drug Discovery (K.J.T., A.L.B., S.R.S., C.W.L.), Vanderbilt University Medical Center, Nashville, Tennessee; and Department of Chemistry, Vanderbilt University, Nashville, Tennessee (S.R.S., C.W.L.)
Shaun R. Stauffer
Department of Pharmacology (M.T.D., K.J.T., J.G.M., A.L.B., S.R.S., C.W.L., H.E.H.) and Vanderbilt Center for Neuroscience Drug Discovery (K.J.T., A.L.B., S.R.S., C.W.L.), Vanderbilt University Medical Center, Nashville, Tennessee; and Department of Chemistry, Vanderbilt University, Nashville, Tennessee (S.R.S., C.W.L.)
Craig W. Lindsley
Department of Pharmacology (M.T.D., K.J.T., J.G.M., A.L.B., S.R.S., C.W.L., H.E.H.) and Vanderbilt Center for Neuroscience Drug Discovery (K.J.T., A.L.B., S.R.S., C.W.L.), Vanderbilt University Medical Center, Nashville, Tennessee; and Department of Chemistry, Vanderbilt University, Nashville, Tennessee (S.R.S., C.W.L.)
Heidi E. Hamm
Department of Pharmacology (M.T.D., K.J.T., J.G.M., A.L.B., S.R.S., C.W.L., H.E.H.) and Vanderbilt Center for Neuroscience Drug Discovery (K.J.T., A.L.B., S.R.S., C.W.L.), Vanderbilt University Medical Center, Nashville, Tennessee; and Department of Chemistry, Vanderbilt University, Nashville, Tennessee (S.R.S., C.W.L.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Strategies for Targeting PAR4 on Human Platelets
Matthew T. Duvernay, Kayla J. Temple, Jae G. Maeng, Anna L. Blobaum, Shaun R. Stauffer, Craig W. Lindsley and Heidi E. Hamm
Molecular Pharmacology January 1, 2017, 91 (1) 39-47; DOI: https://doi.org/10.1124/mol.116.106666
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement